Mendus Ab: Mendus Announces Financing Commitments Totaling Up To Sek 250 Million With Van Herk Investments And Negma Group
Mendus Ab: Mendus Announces Financing Commitments Totaling Up To Sek 250 Million With Van Herk Investments And Negma Group
08/26/22, 5:04 AM
Location
parisMendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company addressing tumor recurrence through cell-based immunotherapies, today announces that it has entered into a binding agreement for a financing commitment of up to SEK 200 million (“Transaction”) with Negma Group Ltd, a Paris-based leading financial institution (“Negma”). The Company has also entered into a binding commitment letter to receive a shareholder loan up to SEK 50 million with its existing shareholder Van Herk Investments.
Company Info
Location
paris, ile-de-france, france
Additional Info
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company addressing tumor recurrence through cell-based immunotherapies, today announces that it has entered into a binding agreement for a financing commitment of up to SEK 200 million (“Transaction”) with Negma Group Ltd, a Paris-based leading financial institution (“Negma”). The Company has also entered into a binding commitment letter to receive a shareholder loan up to SEK 50 million with its existing shareholder Van Herk Investments.